TrialCard News
PRESS RELEASE
U.S. Patent Office Awards TrialCard Inc. With Two Pharmaceutical Product Sampling Technology Patents.
TrialCard's "IA Technology" Reduces Sampling Liability, Provides Actionable ROI Data And Improves Persistency And Compliance Tracking.
Raleigh, NC May 27, 2002 TrialCard Inc., a privately held transaction services company, announced today that it has been awarded a second patent on its method and system for dispensing, tracking and managing pharmaceutical trial products.
TrialCard's patented sampling program technology has been integrated into a series of national drug sampling programs from the leading pharmaceutical companies.
The initial patent (awarded Q4 1998) entails a system and method for dispensing, managing and tracking the distribution of pharmaceutical trial or sample products by linking medical prescribers and pharmacies to a central computing station.
This second patent significantly expands on the claims of the first patent awarded in 1998 and provides critical intellectual property protection in the U.S. and worldwide says David Cunningham, TrialCard CEO and the patent holder.
TrialCard's exclusive IA Technology captures real time ROI sampling data from all points of contact (reps, physicians, patients, pharmacists), thus enabling pharmaceutical companies to effectively measure cause and effect relationships. Moreover, TrialCard powered programs can be activated or deactivated at any point in the sampling process.
About TrialCard:
Headquartered in Raleigh NC, TrialCard, Inc. is a transaction services and data management company specializing in the distribution of drug product for the pharmaceutical industry and allied healthcare organizations. Using patented IA Technology, a process of activating and de-activating magnetic stripe cards, TrialCard can deliver prescription medication to patients through 55,000 pharmacies nationwide while reducing financial exposure for their clients. TrialCard's premier offerings include drug product sampling, direct-to-consumer/physician marketing, Phase IV clinical trials and patient assistance programs. TrialCard's IA Technology provides pharmaceutical companies with the vehicle to increase patient persistency and compliance, effectively measure promotional programs ROI, and accurately track sample distribution from the sales rep to the physician to the patient to the pharmacist.
For more information about TrialCard's services, please contact Chuck Reuben COO (call 919-845-0774, or email creuben@trialcard.com) or visit www.trialcard.com.
|
|
|  | |
